Resultados de procura - Lijin Li
- Mostrando 1 - 7 Resultados de 7
-
1
-
2
Cross-dressed CD8α <sup>+</sup> /CD103 <sup>+</sup> dendritic cells prime CD8 <sup>+</sup> T cells following vaccination por Lijin Li, Sojung Kim, John M. Herndon, Peter S. Goedegebuure, Brian A. Belt, Ansuman T. Satpathy, Timothy P. Fleming, Ted H. Hansen, Kenneth M. Murphy, William E. Gillanders
Publicado 2012Artigo -
3
Safety and Preliminary Evidence of Biologic Efficacy of a Mammaglobin-A DNA Vaccine in Patients with Stable Metastatic Breast Cancer por Venkataswarup Tiriveedhi, Natalia Tucker, John M. Herndon, Lijin Li, Mark Sturmoski, Matthew J. Ellis, X. Cynthia, Michael Naughton, A. Craig Lockhart, Feng Gao, Timothy P. Fleming, Peter S. Goedegebuure, Thalachallour Mohanakumar, William E. Gillanders
Publicado 2014Artigo -
4
cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity por Stephen T. Ferris, Vivek Durai, Renee Wu, Derek J. Theisen, Jeffrey P. Ward, Michael D. Bern, Jesse T. Davidson, Prachi Bagadia, Tiantian Liu, Carlos G. Briseño, Lijin Li, William E. Gillanders, Gregory F. Wu, Wayne M. Yokoyama, Theresa L. Murphy, Robert D. Schreiber, Kenneth M. Murphy
Publicado 2020Artigo -
5
Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translation por Lijin Li, Xiuli Zhang, Xiaoli Wang, Samuel W. Kim, John M. Herndon, Michelle Becker‐Hapak, Beatriz M. Carreno, Nancy B. Myers, Mark Sturmoski, Michael D. McLellan, Christopher A. Miller, Tanner M. Johanns, Benjamin Tan, Gavin P. Dunn, Timothy P. Fleming, Ted H. Hansen, S. Peter Goedegebuure, William E. Gillanders
Publicado 2021Artigo -
6
Breast Cancer Neoantigens Can Induce CD8+ T-Cell Responses and Antitumor Immunity por Xiuli Zhang, Samuel Kim, Jasreet Hundal, John M. Herndon, Shunqiang Li, Allegra A. Petti, Savas D. Soysal, Lijin Li, Michael D. McLellan, Jeremy Hoog, Tina Primeau, Nancy B. Myers, Tammi L. Vickery, Mark Sturmoski, Ian S. Hagemann, Chris Miller, Matthew J. Ellis, Elaine R. Mardis, Ted H. Hansen, Timothy P. Fleming, S. Peter Goedegebuure, William E. Gillanders
Publicado 2017Artigo -
7
Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patients por Xiuli Zhang, S. Peter Goedegebuure, Michael Y. Chen, Rashmi Mishra, Felicia Zhang, Yafei Yu, Kartik Singhal, Lijin Li, Feng Gao, Nancy B. Myers, Tammi L. Vickery, Jasreet Hundal, Michael D. McLellan, Mark Sturmoski, Samuel W. Kim, Ina Chen, Jesse T. Davidson, Narendra V. Sankpal, Stephanie Myles, Rama Suresh, X. Cynthia, Ademuyiwa Foluso, Andrea Wang‐Gillam, Sherri R. Davies, Ian S. Hagemann, Elaine R. Mardis, Obi L. Griffith, Malachi Griffith, Chris Miller, Ted H. Hansen, Timothy P. Fleming, Robert D. Schreiber, William E. Gillanders
Publicado 2024Artigo
Ferramentas de procura:
Materias Relacionadas
Immune system
Immunology
Biology
Medicine
CD8
Cancer
DNA vaccination
Immunization
Immunotherapy
Internal medicine
Antigen
Breast cancer
Cytotoxic T cell
In vitro
T cell
Antigen presentation
Antigen-presenting cell
Biochemistry
Bioinformatics
Botany
Cancer immunotherapy
Cancer vaccine
Computational biology
ELISPOT
Genetics
Germination
Major histocompatibility complex
Oncology
Priming (agriculture)
Allergy